The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Abstract
Background The popular dance drug ecstasy (3,4‐methylenedioxymethamphetamine: MDMA and some analogues) causes selective and persistent neurotoxic damage of central serotonergic neurones in laboratory animals. Serotonin plays a role in numerous functional systems in the central nervous system (CNS). Consequently, various abnormalities including psychiatric, vegetative, neuroendocrine and cognitive disorders could be expected in humans following MDMA‐induced neurotoxic brain damage. Aims In recent years, the question of ecstasy‐induced neurotoxicity and possible functional sequelae has been addressed in several studies with drug users. The aim of this paper was to review this literature and weigh the strength of the evidence for persistent brain damage in ecstasy users. Methods We used Medline to view all available publications on ‘ecstasy’ or ‘MDMA’. All available studies dealing with ecstasy users entered this analysis. Findings and conclusions Despite large methodological problems the bulk of evidence suggests residual alterations of serotonergic transmission in MDMA users, although at least partial restitution may occur after long‐term abstinence. However, functional sequelae may persist even after longer periods of abstinence. To date, the most consistent findings associate subtle cognitive, particularly memory, impairments with heavy ecstasy use. However, the evidence cannot be considered definite and the issues of possible pre‐existing traits or the effects of polydrug use are not resolved. Recommendations Questions about the neurotoxic effects of ecstasy on the brain remain highly topical in light of its popularity among young people. More longitudinal and prospective studies are clearly needed in order to obtain a better understanding of the possible long‐term sequelae of ecstasy use in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Hegerl, U., & Juckel, G. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90137-3 · Cited by 472
Role of serotonin in memory impairment.
Buhot, M.-C., Martin, S., & Segu, L. (2000) · Annals of Medicine · doi:10.3109/07853890008998828 · Cited by 419
SEROTONIN IN THE REGULATION OF BRAIN MICROCIRCULATION
COHEN, Z., BONVENTO, G., LACOMBE, P., & HAMEL, E. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00033-0 · Cited by 314
Increasing MDMA use among college students: results of a national survey
Strote, J., Lee, J. E., & Wechsler, H. (2002) · Journal of Adolescent Health · doi:10.1016/s1054-139x(01)00315-9 · Cited by 245
(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies
McCann, U. D., Eligulashvili, V., & Ricaurte, G. A. (2000) · Neuropsychobiology · doi:10.1159/000026665 · Cited by 190
Mechan, A., Yuan, J., Hatzidimitriou, G., Irvine, R. J., McCann, U. D., & Ricaurte, G. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300808 · Cited by 67
Cited by
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., Martin, S. F., Yazar-Klosinski, B., Michel, Y., Brewerton, T. D., & Doblin, R. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112456611 · Cited by 376
Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana
Schierenbeck, T., Riemann, D., Berger, M., & Hornyak, M. (2008) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2007.12.004 · Cited by 291
Abuse of Amphetamines and Structural Abnormalities in the Brain
Berman, S., O'Neill, J., Fears, S., Bartzokis, G., & London, E. D. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.031 · Cited by 253
Ersche, K. D., Roiser, J. P., Robbins, T. W., & Sahakian, B. J. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1051-1 · Cited by 252
Alcohol and drugs in epilepsy: Pathophysiology, presentation, possibilities, and prevention
Leach, J. P., Mohanraj, R., & Borland, W. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03613.x · Cited by 105
Metadata
- Authors
- Gouzoulis‐Mayfrank, E., & Daumann, J.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2006-02-27
- Volume
- 101
- Issue
- 3
- Pages
- 348-361
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2110876011
- Cited by
- 189
- References
- 8
- FWCI
- 19.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? https://app.cochat.ai/papers/10.1111/j.1360-0443.2006.01314.x
- The paper
- Gouzoulis‐Mayfrank, E., & Daumann, J. (2006). Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? Addiction. https://doi.org/10.1111/j.1360-0443.2006.01314.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.